• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Review Finds Intraoperative IDH Detection Lacks Validated Margin Assessment Evidence

by
November 17, 2026
in Cancer
Reading Time: 3 mins read
0
Review Finds Intraoperative IDH Detection Lacks Validated Margin Assessment Evidence

Review Finds Intraoperative IDH Detection Lacks Validated Margin Assessment Evidence

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A scoping review evaluating intraoperative detection technologies for diffuse glioma surgery found that while isocitrate dehydrogenase assessment has transitioned toward spatial margin analysis, no validated molecular margin tool currently exists. Researchers examined whether techniques identifying isocitrate dehydrogenase mutation status or its metabolic surrogate, D-2-hydroxyglutarate, have advanced from basic tumour classification to active intraoperative margin guidance. Although surgical extent of resection directly predicts patient survival in isocitrate dehydrogenase-mutant diffuse glioma, infiltrative neoplastic cells routinely extend beyond visually discernible tissue or conventional neuroimaging boundaries, complicating definitive surgical clearance.

To determine whether current analytical systems reliably inform intraoperative surgical decision-making, the investigators implemented a systematic scoping review guided by the PRISMA-ScR framework. The team formulated formal study eligibility around a structured Population, Concept, and Context paradigm. This protocol captured research involving diffuse glioma tissue specimens alongside experimental models, specifically evaluating intraoperatively feasible or proposed analytical platforms configured to measure isocitrate dehydrogenase alterations, D-2-hydroxyglutarate accumulation, or downstream linked diagnostic signals across surgical margin and infiltration zones.

The research team performed systematic electronic literature searches spanning Ovid MEDLINE, Ovid Embase, Web of Science, and Google Scholar, capturing all relevant candidate reports indexed through 15 July 2026. Study selection adhered to rigorous methodological standards, with two independent reviewers completing title, abstract, and full-text screening in duplicate to identify eligible publications. Through this process, the investigators identified and selected thirty-seven unique published studies examining intraoperative identification platforms in diffuse glioma surgery for detailed qualitative synthesis.

Among the thirty-seven included studies, twenty-six investigations specifically focused on isocitrate dehydrogenase-linked detection methodologies. However, only twelve of these twenty-six studies progressed to evaluating molecular or metabolic readouts within a defined spatial context across tissue boundaries. The remaining investigations evaluated bulk tissue samples without resolving boundary-specific margins, illustrating a predominant developmental emphasis on initial diagnostic tumour classification rather than real-time microscopic boundary discrimination during ongoing operative intervention.

Crucially, the review identified substantial diagnostic and analytical evidence gaps across all evaluated margin platforms. None of the included isocitrate dehydrogenase-linked studies established formal diagnostic sensitivity or negative predictive values for local tumour presence at sampled boundary locations verified against an independent, site-matched reference standard. Furthermore, analytical classification thresholds were overwhelmingly developed using bulk tissue or dense tumour core specimens, even though true infiltration edges typically feature markedly reduced cellularity and heterogeneous neoplastic infiltration.

Reported surgical workflows and testing runtimes exhibited extreme variability across different technological modalities. Operational analysis durations spanned from less than three seconds for rapid optical Raman spectroscopy techniques to approximately one hundred minutes for polymerase chain reaction platforms. In addition, sampling strategies and operative margin definitions lacked standardization across institutions. Only two identified studies described extending surgical resection based upon a positive boundary signal, and neither investigation demonstrated measurable, attributable clinical benefit resulting from that additional tissue removal.

The authors concluded that clinical translation of intraoperative isocitrate dehydrogenase detection into validated decision tools demands rigorous, boundary-specific empirical validation. Future translational efforts must establish consistent spatial margin definitions, validate diagnostic thresholds specifically within low-cellularity infiltration zones, and conduct robust site-matched evaluations of both positive and negative analytical readouts. Establishing these rigorous diagnostic benchmarks remains essential before molecular margin readouts can safely guide decisions to resect further tissue or terminate surgical excision.

Subject of Research: Scoping review of intraoperative IDH-linked tumour margin detection in diffuse glioma surgery

Article Title: From tumour classification to tumour margin assessment: a scoping review of intraoperative IDH-linked detection in diffuse glioma surgery

Article References: Sheridan, E. M., Govaerts, C. W., & Price, S. J. (2026). From tumour classification to tumour margin assessment: a scoping review of intraoperative IDH-linked detection in diffuse glioma surgery. Journal of Neuro-Oncology Discovery. https://doi.org/10.1007/s44499-026-00012-9

Image Credits: AI Generated

DOI: 10.1007/s44499-026-00012-9

Keywords: diffuse glioma, IDH mutation, intraoperative detection, tumour margin assessment, extent of resection, D-2-hydroxyglutarate, scoping review, PRISMA-ScR, surgical decision support, Raman spectroscopy, polymerase chain reaction, molecular margins, tumour infiltration, site-matched reference, negative predictive value, low-cellularity tissue, boundary-specific validation

News Source: Nathaniel Bowman. (November 17, 2026). Review Finds Intraoperative IDH Detection Lacks Validated Margin Assessment Evidence. Scienmag.

Tags: boundary-specific validationD-2-hydroxyglutaratediffuse gliomaextent of resectionIDH mutationintraoperative detectionlow-cellularity tissuemolecular marginsnegative predictive valuepolymerase chain reactionPRISMA-ScRRaman spectroscopyscoping reviewsite-matched referencesurgical decision supporttumour infiltrationtumour margin assessment
Share12Tweet7Share2ShareShareShare1

Related Posts

Network Meta-Analysis Ranks Herbal Medicines for Radiation-Induced Oral Mucositis in Cancer

Network Meta-Analysis Ranks Herbal Medicines for Radiation-Induced Oral Mucositis in Cancer

November 19, 2026
Bibliometric Analysis Maps Decadelong Rise in Cancer Stromal Crosstalk Research

Bibliometric Analysis Maps Decadelong Rise in Cancer Stromal Crosstalk Research

November 19, 2026

Preoperative MRI Predicts Urinary Continence Recovery Following Radical Prostatectomy

November 19, 2026

Cancer Studies Omit Age and Sex Data on Drug Conjugate Nausea

November 19, 2026

POPULAR NEWS

  • Updated ArrayAnalysis Platform Expands Interactive Analysis for Microarray and RNA-seq Data

    Updated ArrayAnalysis Platform Expands Interactive Analysis for Microarray and RNA-seq Data

    29 shares
    Share 12 Tweet 7
  • Stem Cells in Pituitary Tumors Show Multilineage Endocrine Potential

    29 shares
    Share 12 Tweet 7
  • Biotechnology Advances Expand Broodstock Management and Artificial Reproduction in Rainbow Trout

    29 shares
    Share 12 Tweet 7
  • Non-Vascular Ehlers-Danlos Surgery Carries High Complication Rates but No Life-Threatening Risks

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Yasothon Ethnobotanical Survey Identifies Cultivated Multipurpose Plants Dominating Rural Households

Phase II Trial Tests Glycerol Phenylbutyrate for Slowing Corticobasal Syndrome Progression

Study Documents 78 Traditional Non-Animal Foods in Central Asian Steppe

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.